Methylnaltrexone

/Tag:Methylnaltrexone

TREATMENT WITH METHYLNALTREXONE IN PATIENTS WITH OPIOID-INDUCED CONSTIPATION WITH OR WITHOUT ACTIVE CANCER

Background: Subcutaneous (SC) methylnaltrexone (MNTX) is approved for opioid-induced constipation (OIC) in adults with chronic noncancer pain and OIC in adults with advanced illness or with active cancer who require opioid dosage escalation for palliative [...]

By | 2019-03-11T14:26:19+00:00 March 11th, 2019|Hospital Medicine 2019, Research, Translating Research into Practice|Comments Off on TREATMENT WITH METHYLNALTREXONE IN PATIENTS WITH OPIOID-INDUCED CONSTIPATION WITH OR WITHOUT ACTIVE CANCER